Phase II trial of irinotecan and cisplatin combination as first-line chemotherapy in patients with advanced esophageal squamous-cell carcinoma: An interim report

被引：1
作者：
Zhang, X.
Shen, L.
Li, J.
Li, Y.
Zhou, J.
Lu, Z.
Lu, M.
机构：
[1] Peking Univ, Canc Hosp & Inst, Dept Gastrointestinal Oncol, Beijing 100871, Peoples R China
[2] Peking Univ, Canc Hosp, Dept Gastrointestinal Oncol, Beijing 100871, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.137
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
137
引用
收藏
页数：1
相关论文
共 50 条
[21]   Phase II trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck [J].
Glisson, BS ;
Murphy, BA ;
Frenette, G ;
Khuri, FR ;
Forastiere, AA .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) :1593-1599
[22]   Complete response of advanced esophageal squamous cell carcinoma with first-line chemotherapy combined with immunotherapy: a Case report [J].
Wei, Yahong ;
Han, Shaohui ;
Shi, Yabin ;
Li, Yaxing ;
Zhang, Qi ;
Zhang, Lijuan ;
Cheng, Yan ;
Yan, Xiaolu ;
Jia, Yitao .
FRONTIERS IN IMMUNOLOGY, 2025, 16
[23]   Evaluation of safety and tolerability of durvalumab (D) and tremelimumab (T) in combination with first-line chemotherapy in patients (pts) with esophageal squamous-cell carcinoma (ESCC). [J].
Lee, Dae Ho ;
Kim, HyeRyun ;
Keam, Bhumsuk ;
Kato, Ken ;
Kuboki, Yasutoshi ;
Vlahovic, Gordana ;
Takahashi, Osamu ;
Fitts, David ;
Ahn, Myung-Ju .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
[24]   Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study [J].
Lee, Su Jin ;
Kim, Sungmin ;
Kim, Moonjin ;
Lee, Jeeyun ;
Park, Yeon Hee ;
Im, Young-Hyuck ;
Park, Se Hoon .
BMC CANCER, 2015, 15
[25]   Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study [J].
Su Jin Lee ;
Sungmin Kim ;
Moonjin Kim ;
Jeeyun Lee ;
Yeon Hee Park ;
Young-Hyuck Im ;
Se Hoon Park .
BMC Cancer, 15
[26]   Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma [J].
Li, Yu-Hong ;
Wang, Feng-Hua ;
Jiang, Wen-Qi ;
Xiang, Xiao-Juan ;
Deng, Yan-Ming ;
Hu, Guo-Qing ;
Xu, De-Ming ;
Chen, Yan ;
Lin, Qing ;
He, You-Jian .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (03) :539-544
[27]   Phase II trial of second-line chemotherapy with docetaxel and capecitabine in advanced esophageal squamous cell carcinoma [J].
Xuyuan Li ;
Wen Lin ;
Hongbiao Wang ;
Wenzhao Lin ;
Suiling Lin ;
Yingcheng Lin .
Medical Oncology, 2013, 30
[28]   Phase II trial of second-line chemotherapy with docetaxel and capecitabine in advanced esophageal squamous cell carcinoma [J].
Li, Xuyuan ;
Lin, Wen ;
Wang, Hongbiao ;
Lin, Wenzhao ;
Lin, Suiling ;
Lin, Yingcheng .
MEDICAL ONCOLOGY, 2013, 30 (04)
[29]   Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma [J].
Tanaka, Yoshihiro ;
Yoshida, Kazuhiro ;
Yamada, Atsuko ;
Tanahashi, Toshiyuki ;
Okumura, Naoki ;
Matsuhashi, Nobuhisa ;
Yamaguchi, Kazuya ;
Miyazaki, Tatsuhiko .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (06) :1143-1152
[30]   Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma [J].
Yu-Hong Li ;
Feng-Hua Wang ;
Wen-Qi Jiang ;
Xiao-Juan Xiang ;
Yan-Ming Deng ;
Guo-Qing Hu ;
De-Ming Xu ;
Yan Chen ;
Qing Lin ;
You-Jian He .
Cancer Chemotherapy and Pharmacology, 2008, 62 :539-544
12345